Jisandai (Epclusa/Epclusa) Indian version latest price and purchase channel reference instructions

Epclusa is an oral antiviral combination preparation, consisting of Sofosbuvir and Velpatasvir. It is a direct-acting antiviral drug (DAA). It can simultaneously inhibit HCV's NS5B polymerase and NS5A protein, blocking the entire process of viral replication, thereby achieving the purpose of curing chronic hepatitis C (HCV) infection. The drug has broad-spectrum efficacy against all HCV genotypes and is currently one of the internationally recognized preferred treatment options.

Ji Sandai has been officially launched in China and has been included in the national medical insurance system. Patients can purchase it directly at the hospital or designated pharmacies. According to domestic market information, the price of a box of third-generation Jiji is about more than 3,000 yuan. The specific price varies due to regional differences and different medical insurance policies. When purchasing medicines, patients are advised to consult the local hospital pharmacy about the medical insurance reimbursement ratio and actual out-of-pocket amount to reasonably arrange treatment costs.

In the international market, the prices of generic drugs from India and Bangladesh are more affordable. The price of a single box of the Indian version of the third generation of Ji is only a few hundred yuan, and the drug ingredients and specifications are basically the same as the domestic original drugs, and can provide similar curative effects to the original drugs. This provides a viable option for patients with limited financial capacity, especially those who require long-term treatment or coverage of all HCV genotypes.

Domestic patients should give priority to purchasing Jisandai through regular hospital and pharmacy channels to ensure drug quality and efficacy. If you choose generic drugs from India or Bangladesh, you need to go through legal overseas channels or professional drug platforms, and check the drug ingredients, manufacturer and expiration date to ensure safety. During the medication period, you should strictly follow the doctor's instructions, complete the full course of treatment (usually 12 weeks), and review liver function and virological indicators regularly to ensure successful treatment and reduce the risk of recurrence.

Reference materials:https://www.drugs.com/